Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention

被引：0
|
作者：
Dottino, J. A. [1 ]
Cliby, B. A. [2 ]
Myers, E. R. [3 ]
Bristow, R. E. [4 ]
Havrilesky, L. J. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Mayo Clin, Rochester, MN USA
[3] Duke Univ Hosp, Durham, NC USA
[4] Univ Calif Irvine, Irvine, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.473
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
468
引用
收藏
页码：188 / 189
页数：3
相关论文
共 50 条
  • [41] High-volume facilities are significantly more likely to use guideline-adherent systemic immunotherapy for metastatic Merkel cell carcinoma: implications for cancer care regionalization
    Shayan Cheraghlou
    Vartan Pahalyants
    Neil K. Jairath
    Nicole A. Doudican
    John A. Carucci
    Archives of Dermatological Research, 316
  • [42] NCCN's Value Pathways: The Drive for Quality Cancer Care
    Goldsmith, Patricia J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (02): : 119 - 120
  • [43] Disparities in Receipt of National Comprehensive Cancer Network Guideline-Adherent Care and Outcomes among Women with Triple-Negative Breast Cancer by Race/Ethnicity, Socioeconomic Status, and Insurance Type
    Ubbaonu, Chimezie D.
    Chang, Jenny
    Ziogas, Argyrios
    Mehta, Rita S.
    Kansal, Kari J.
    Zell, Jason A.
    CANCERS, 2023, 15 (23)
  • [44] Screening for Palliative Care: Implementation of the NCCN Guideline at a Comprehensive Cancer Center (418-A)
    Glare, Paul
    Plakovic, Kathy
    Egan, Barbara
    Kelsen, David
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2012, 43 (02) : 387 - 388
  • [45] Models of Care and NCCN Guideline Adherence in Very-Low-Risk Prostate Cancer
    Aizer, Ayal A.
    Paly, Jonathan J.
    Zietman, Anthony L.
    Nguyen, Paul L.
    Beard, Clair J.
    Rao, Sandhya K.
    Kaplan, Irving D.
    Niemierko, Andrzej
    Hirsch, Michelle S.
    Wu, Chin-Lee
    Olumi, Aria F.
    Michaelson, M. Dror
    D'Amico, Anthony V.
    Efstathiou, Jason A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (11): : 1364 - 1372
  • [46] Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival—a retrospective multi-centre cohort study
    L. Schwentner
    R. Wolters
    K. Koretz
    M. B. Wischnewsky
    R. Kreienberg
    R. Rottscholl
    A. Wöckel
    Breast Cancer Research and Treatment, 2012, 132 : 1073 - 1080
  • [47] Does Guideline-Adherent Therapy Improve the Outcome for Early-Onset Breast Cancer Patients? (vol 78, pg 189, 2010)
    Varga
    ONCOLOGY, 2010, 79 (3-4) : 305 - 305
  • [48] Disparities in the receipt of National Comprehensive Cancer Network (NCCN) guideline adherent care in triple-negative breast cancer (TNBC) by race/ethnicity, socioeconomic status, and insurance type.
    Ubbaonu, Chimezie
    Chang, Jenny
    Ziogas, Argyrios
    Clair, Kiran
    Tanjasiri, Sora Park
    Bristow, Robert E.
    Patel, Neha
    Mehta, Rita S.
    Kansal, Kari Joanne
    Zell, Jason A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] The NCCN 2019 Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care
    Carlson, Robert W.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (05): : 529 - 530
  • [50] Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival-a retrospective multi-centre cohort study
    Schwentner, L.
    Wolters, R.
    Koretz, K.
    Wischnewsky, M. B.
    Kreienberg, R.
    Rottscholl, R.
    Woeckel, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (03) : 1073 - 1080
12345